Cargando…
Chronic heart failure: the role of di vericiguat
The introduction of multiple new pharmacological agents over the past three decades in the field of heart failure with reduced ejection fraction (HFrEF) has led to reduced rates of mortality and hospitalizations, and consequently, the prevalence of HFrEF has increased, and up to 10% of patients prog...
Autores principales: | Caminiti, Giuseppe, Sposato, Barbara, Volterrani, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132584/ https://www.ncbi.nlm.nih.gov/pubmed/37125270 http://dx.doi.org/10.1093/eurheartjsupp/suad056 |
Ejemplares similares
-
The role of iron deficiency in heart failure
por: Caminiti, Giuseppe, et al.
Publicado: (2023) -
Multimodality imaging in decompensated heart failure
por: D’Andrea, Antonello, et al.
Publicado: (2023) -
Acute heart failure: differential diagnosis and treatment
por: Marini, Marco, et al.
Publicado: (2023) -
Advanced heart failure: from definitions to therapeutic options
por: Garascia, Andrea, et al.
Publicado: (2023) -
Management of heart failure: similarities and discrepancies between the European Society of Cardiology and the American Heart Association guidelines
por: Parlati, Antonio Luca Maria, et al.
Publicado: (2023)